According to InfuSystem's latest financial reports the company's current EPS (TTM) is $0.03000. In 2022 the company made an earnings per share (EPS) of $0.0000000000 a decrease over its 2021 EPS that were of $0.07000.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.03000 | 1.7293822569103E+18% |
2022 | $0.0000000000 | -100% |
2021 | $0.07000 | -91.95% |
2020 | $0.87 | 1142.86% |
2019 | $0.07000 | -240% |
2018 | -$0.05000 | -94.57% |
2017 | -$0.92 | 16023.38% |
2016 | -$0.005706 | -103.8% |
2015 | $0.15 | -6.25% |
2014 | $0.16 | 107.41% |
2013 | $0.07714 | -212.66% |
2012 | -$0.06847 | -96.83% |
2011 | -$2.16 | 2300% |
2010 | -$0.09000 | -325% |
2009 | $0.04000 | -92.98% |
2008 | $0.57 | -480% |
2007 | -$0.15 | -74.14% |
2006 | -$0.58 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Premier PINC | $1.54 | 5,033.33% | ๐บ๐ธ USA |
DexCom DXCM | $0.98 | 3,166.67% | ๐บ๐ธ USA |
CorVel Corporation
CRVL | $4.36 | 14,433.33% | ๐บ๐ธ USA |
Biolase
BIOL | -$264.93 | -883,200.00% | ๐บ๐ธ USA |